Welcome to our dedicated page for STEAKHOLDER FOODS news (Ticker: STKH), a resource for investors and traders seeking the latest updates and insights on STEAKHOLDER FOODS stock.
Steakholder Foods Ltd (STKH) pioneers sustainable protein solutions through advanced 3D bioprinting technology, creating plant-based and cultivated meat alternatives that replicate traditional textures. This hub provides investors and industry observers with essential updates on the company's technological advancements, market strategies, and regulatory milestones.
Discover official press releases covering product innovations like the MX200 printer's FPL™ layering system, partnership announcements with food manufacturers, and progress in cellular agriculture research. Our curated news collection enables efficient tracking of STKH's commercial deployments and scientific breakthroughs in alternative protein production.
Key content categories include earnings reports, equipment launches, premix blend developments, and sustainability initiatives. Bookmark this page for real-time updates on how STKH's 3D printing solutions address global demand for ethical food production while maintaining operational scalability for manufacturers.
Steakholder Foods Ltd. (NASDAQ: STKH) announced a breakthrough in cultured meat technology by successfully differentiating porcine fat cells from its induced pluripotent stem cell line. This achievement supports the scalability of high-quality 3D-printed pork products. The company also secured its first Canadian patent, enhancing its intellectual property portfolio, which includes similar patents in the US, Australia, and New Zealand. Steakholder Foods continues to innovate in the slaughter-free meat production sector, contributing to sustainability and food security.
Steakholder Foods Ltd. (NASDAQ: STKH) announced the receipt of its first registered trademark in Japan, marking a significant milestone for its entry into Asian markets. This comes alongside a collaboration with Singaporean company Umami Meats to produce 3D-printed seafood products tailored for the Japanese market. The partnership aims to diversify Steakholder's portfolio, which currently includes bovine, avian, and porcine products. As Japan considers regulatory frameworks for cultivated meat commercialization, Steakholder is positioning itself strategically within the burgeoning cultured meat sector.
Steakholder Foods Ltd. (STKH) has received a significant boost with the grant of a patent from the US Patent and Trademark Office. This patent focuses on systems and methods to apply external forces to muscle tissue, enhancing texture for cultured meat. This achievement strengthens Steakholder’s competitive position in the cultured meat sector, following similar patent grants in Australia and New Zealand earlier this year. The patent addresses one of the main challenges in producing textured, high-quality cultured meat that emulates traditional meat characteristics, thus advancing their proprietary technology.
Steakholder Foods Ltd. (NASDAQ: STKH) announced the release of a new investor presentation ahead of the 21st World Congress of Food Science & Technology in Singapore, where CEO Arik Kaufman will present. The presentation outlines the company's recent achievements, financial overview, and strategies in the cultured meat sector. It emphasizes Steakholder's impact on social, environmental, and business fronts while adhering to the UN's sustainable development goals. This rebranding follows the company's evolution from MeaTech 3D and anticipates future growth in the cultured protein market.
Steakholder Foods Ltd. (NASDAQ: STKH) has filed a provisional patent application with the U.S. Patent Office for a novel method to enhance fat differentiation from stem cells, aimed at increasing yields and reducing production costs. This initiative aligns with the company's commitment to minimizing reliance on animal-based components. Steakholder's patent portfolio now includes one granted patent and 15 applications, emphasizing its focus on innovating in the cultured meat sector. CEO Arik Kaufman underscored the significance of this filing in advancing their business goals.
Steakholder Foods Ltd. (Nasdaq: STKH) has initiated the development of a bovine cell line in the US, utilizing cells from USDA-approved cattle. This move is part of the company's strategy to align with regulatory standards as it seeks approval for cultured meat products in the US. The USDA will play a key role in this process, with Steakholder ensuring the health and quality of the sourced cells. CEO Arik Kaufman expressed enthusiasm about this advancement, highlighting the company's commitment to safety and quality in sustainable meat production.
Steakholder Foods Ltd. (Nasdaq: STKH) addressed its recent trading concerns, stating no significant undisclosed negative developments. CEO Arik Kaufman reassured shareholders that operations in research, development, and commercialization continue as planned. The company remains focused on its mission to revolutionize the cultured meat industry, producing meat alternatives without slaughter. With facilities in Israel, Belgium, and expanding to the U.S., Steakholder Foods is committed to sustainability and food security.
Steakholder Foods (Nasdaq: STKH) will showcase its 3D bioprinting technology at the Future Food-Tech Summit in London on September 22-23, 2022. Attendees can print personalized steaks in real-time, choosing from Entrecote, Sirloin, or Picanha with varying fat ratios. The printed steaks will undergo further maturation at Steakholder Foods' facilities. The company aims to connect with over 600 industry innovators for potential collaborations and partnerships, focusing on sustainable food production.
Steakholder Foods Ltd. (Nasdaq: STKH) has introduced Omakase Beef Morsels, a groundbreaking 3D-printed cultured meat product showcasing advanced marbling control and unprecedented product consistency. Developed from bovine stem cells, this innovative offering mimics the marbling of premium Wagyu beef through a unique printing process using two bio-inks for muscle and fat. The company recently filed a patent for this technology, enhancing its position in the cultured meat market. Steakholder aims to inspire culinary creativity while aligning with sustainable food production goals.
Steakholder Foods (Nasdaq: STKH) reported its Q2 2022 financial results, revealing a 37% increase in operating loss to $4.8 million compared to $3.5 million in Q2 2021. R&D expenses rose by 28% to $2.3 million, while total comprehensive loss reached $6.6 million or 3 cents per share. Cash and equivalents declined 56% to $8.4 million. However, the company raised $6.5 million in capital after the quarter, enhancing its liquidity. Steakholder Foods continues to advance in cultured meat development with a focus on 3D bioprinting systems and strategic collaborations.
